Onyx is designed to enable scientists to create libraries of millions of precisely-engineered single cells in one experiment through a fully automated workflow that enables massively parallel, trackable editing of single cells at an unprecedented scale. Onyx sells for a list price of $347,000 . . .
The post Inscripta Eyes Broader Genome Editing Reach with $150M Series E appeared first on GEN – Genetic Engineering and Biotechnology News.